Periareolar mastopexy with FortaPerm

Area of Science:

• Plastic Surgery
• Biomaterials Science

Background:

• Recurrent ptosis is a frequent complication following mastopexy (breast lift surgery).
• Mesh materials are used with the double-skin technique to minimize recurrent ptosis.
• An ideal mesh requires a balance of persistence, biocompatibility, and incorporation without adverse effects.

Purpose of the Study:

• To evaluate FortaPerm, a biologic tissue matrix, as an adjunct for mastopexy.
• To assess FortaPerm's efficacy in preventing recurrent ptosis and its safety profile.
• To determine if FortaPerm impacts mammographic imaging.

Main Methods:

• Prospective observational study involving women undergoing mastopexy with FortaPerm.
• Long-term follow-up for up to 5 years with photographic and clinical assessments.
• Secondary assessments included mammography, patient/physician global evaluations, and pain assessments.

Main Results:

• At 12 months, 80% of patients (4/5) showed no asymmetry or ptosis; at 5 years, 66% (2/3) maintained results.
• FortaPerm did not affect mammographic evaluations, showing no abnormal findings.
• Two patients developed bilateral seromas, with minor FortaPerm extrusion but no significant inflammation.

Conclusions:

• FortaPerm demonstrated excellent aesthetic outcomes and sustained breast position maintenance post-mastopexy.
• The biologic tissue matrix did not interfere with mammography and showed no long-term safety issues.
• FortaPerm yielded satisfactory results regarding scar appearance, breast shape, and firmness.